查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1804579

醫療設備中的螢光（按技術、磷光體類型、應用和最終用戶）—2025-2030 年全球預測

Fluorescence in Medical Device Market by Technology, Fluorophore Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年醫療設備螢光市場規模將達48.1億美元，2025年將成長至52.5億美元，複合年成長率為9.45%，到2030年將達到82.8億美元。

主要市場統計數據
基準年2024年 48.1億美元
預計2025年 52.5億美元
預測年份 2030 82.8億美元
複合年成長率（%） 9.45%

透過基本觀點、新興趨勢和塑造醫療技術格局的關鍵促進因素，闡明醫療設備螢光的未來

螢光技術在臨床影像和診斷應用中具有無與倫比的敏感度和特異性，已成為醫療設備創新的關鍵。透過利用特定波長激發的磷光體團的獨特光學特徵，開發人員可以以驚人的精度可視化組織結構、指導手術干預並監測治療反應。這項基礎技術徹底改變了傳統的診斷方法，透過微創手術和即時視覺化功能改善了患者的治療效果。

透過技術突破、監管演變和臨床應用趨勢追蹤醫學螢光應用的變革

近年來，一系列技術突破推動了醫療設備中螢光的發展，這些突破重新定義了診斷和治療的可能性。螢光成像系統的創新實現了更高的空間解析度和更深的組織穿透能力，而光譜技術的進步則增強了對生物分子相互作用的定量分析。同時，新型螢光染料和藥物的光穩定性和標靶遞送機制的改進，拓展了螢光在各種臨床環境中的應用範圍。這些技術飛躍與人工智慧和機器學習演算法的整合相輔相成，最佳化了訊號解讀並減少了對操作員的依賴，從而提高了工作流程效率和診斷準確性。

2025年美國關稅調整計畫對醫療設備螢光供應鏈與定價動態的累積影響分析

美國政府2025年關稅計畫的實施對醫療設備螢光產業而言正值關鍵時刻。這些調整涵蓋了各種進口組件，從光學濾光片和光源到專用螢光染料和成像模組，不一而足。因此，製造商可能面臨進口關稅上調，從而可能增加原料和成品的成本。預計這些關稅變化的累積影響將透過供應鏈結構的變化體現出來，包括供應商組合的潛在轉變以及更注重國內生產以降低成本風險。此外，關稅變化也促使相關人員重新評估其長期籌資策略，並評估垂直整合製造流程的可行性。

從螢光市場技術、磷光體類型、應用模式和最終用戶垂直領域的垂直細分中獲得關鍵見解

依技術細分螢光市場，可以揭示成像系統、光譜平台以及螢光染料和試劑等細分領域中不同的成長動力和應用。螢光成像系統因其提供即時視覺回饋的能力，在手術室中越來越受歡迎，而光譜技術的進步則支持在實驗室中進行詳細的分子分析。同時，螢光染料和試劑也不斷發展，提高光穩定性和標靶特異性，進而增強診斷準確性和治療監測。這種基於技術的觀點使相關人員能夠識別創新最集中的領域以及仍需關注的技術障礙。

了解美洲、中東和非洲以及亞太地區的區域動態和成長模式，推動策略市場擴張

美洲地區的區域動態持續受到北美醫療基礎設施強勁投資和重要創新叢集的影響。美國在螢光醫療設備開發方面處於領先地位，並得到了強大的創業投資資金、大學研究和優惠的報銷模式的支持。加拿大緊隨其後，在國家衛生優先事項和合作研究舉措的推動下，其採用率不斷提高。在拉丁美洲市場，經濟波動和監管分歧既帶來了挑戰，也帶來了機會。為了滿足主要城市中心對先進診斷和外科解決方案日益成長的需求，當地製造商正在逐步採用螢光技術。

重點介紹醫療設備螢光領域主要參與者的競爭策略和創新，以發掘差異化和合作的機會

螢光醫療設備領域的主要企業已展示出各種策略方法，以保持競爭優勢並促進創新。領先的設備製造商優先透過內部開發和收購專業技術公司來擴展其螢光成像產品組合。透過將下一代檢測器和人工智慧主導的軟體整合到現有平台中，這些公司提高了診斷準確性並簡化了臨床工作流程。同時，化學品供應商正在投資開發具有卓越生物相容性和夥伴關係能力的先進螢光染料，並與設備製造商合作開發符合嚴格監管要求的整合解決方案。

為產業領導者提供策略建議，以加速創新、適應法規並加強螢光技術的市場地位

為了充分利用不斷發展的螢光技術，產業領導者應採取多管齊下的策略，在創新與營運韌性之間取得平衡。首先，透過多元化零件採購和發展區域製造中心來增強供應鏈的穩健性，可以降低關稅波動和物流中斷帶來的風險。同時，針對性地投資下一代螢光染料和模組化成像平台的研發，可以幫助企業保持臨床創新的領先地位，並增強其應對複雜診斷和治療挑戰的能力。

調查方法強調主要和次要研究資料的收集、檢驗過程和分析框架，以深入了解螢光市場

本報告背後的調查方法結合了嚴謹的一手資料和二手資料收集，以確保全面涵蓋並深入洞察。一手資料研究包括與關鍵意見領袖（包括生物醫學工程師、臨床醫生、監管專家和採購經理）進行結構化訪談。此外，我們還對設備製造商、化學品供應商和最終用戶進行了調查，以獲得有關性能標準、應用促進因素和市場挑戰的第一手見解。這些定性資訊檢驗了螢光技術開發和商業化中新興的主題。

綜合關鍵發現並預測策略意義，以引導相關人員實現螢光的未來創新和永續成長

本執行摘要提煉了醫療設備螢光領域最具影響力的發展，重點介紹了成像系統、光譜學和磷光體設計的技術突破。摘要也檢驗了即將到來的關稅調整及其重塑供應鏈和成本結構的可能性。本報告對技術、螢光團類型、應用領域和最終用戶群體進行了細分分析，提供了對市場重點的細緻觀點。區域洞察詳細介紹了美洲、中東和非洲以及亞太地區的不同動態。競爭分析重點介紹了領先公司如何利用夥伴關係、本地生產和產品創新來保持競爭優勢。切實可行的建議為應對複雜的監管環境、增強韌性和推動持續創新提供了清晰的藍圖。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 擴展近紅外線螢光探針用於腫瘤學應用中的深層組織成像
  • 將近紅外線螢光成像與機器人手術系統相結合可增強腫瘤可視化
  • 引進人工智慧螢光分析軟體，增強組織分化
  • 新興穿戴式螢光生物感測器，用於持續監測代謝生物標記
  • 醫院與生物技術公司合作商業化新型螢光顯影劑
  • 腫瘤學中即時術中螢光引導腫瘤邊緣檢測工具的進展
  • 結合螢光和超音波的雙模臨床成像平台的開發
  • 用於血管映射和皮膚病學評估的手持螢光成像設備的成長
  • 監管協調和標準化工作推動螢光醫療設備的全球商業化
  • 微創診斷程序中對3D螢光顯微鏡的需求不斷增加

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章醫療設備市場中的螢光（依技術）

  • 螢光成像系統
  • 螢光光譜法
  • 螢光染料和螢光

第9章醫療設備市場中的螢光磷光體

  • 內源性磷光體
  • 外在磷光體

第 10 章。醫療設備市場中的螢光（依應用）

  • 導管螢光
  • 螢光導航手術
    • 心血管外科
    • 神經外科
    • 外科腫瘤學
    • 整形外科
  • 影像學診斷
    • 內視鏡螢光成像
    • 螢光顯微鏡
    • 基於螢光的眼科成像
    • 體內螢光成像
  • 治療

第 11 章。醫療設備市場中的螢光（依最終用戶）

  • 診斷實驗室
  • 醫院和診所
  • 研究和學術機構

12.美國醫療設備螢光市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 歐洲、中東和非洲醫療設備螢光市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

14. 亞太地區醫療設備螢光市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • ADVACAM sro
    • Arthrex, Inc.
    • Bruker Corporation
    • Carl Zeiss AG.
    • Getinge AB
    • Hamamatsu Photonics KK
    • KARL STORZ SE & Co. KG
    • Leica Microsystems GmbH
    • LI-COR Biotech, LLC
    • Mauna Kea Technologies
    • Medtronic International Trading Sarl
    • MolecuLight Inc.
    • Olympus Corporation of the Americas
    • OnLume Inc.
    • Optomedic.
    • PerkinElmer US LLC
    • PicoQuant GmbH
    • Shimadzu Corporation
    • Stryker Corporation
    • Xuzhou Hengjia Electronic Technology Co., Ltd.
    • SurgiMab SAS

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-4545435F211F

The Fluorescence in Medical Device Market was valued at USD 4.81 billion in 2024 and is projected to grow to USD 5.25 billion in 2025, with a CAGR of 9.45%, reaching USD 8.28 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.81 billion
Estimated Year [2025] USD 5.25 billion
Forecast Year [2030] USD 8.28 billion
CAGR (%) 9.45%

Illuminating the Future of Medical Device Fluorescence Through Foundational Perspectives, Emerging Trends, and Key Drivers Shaping Healthcare Technology Landscape

Fluorescence technology has emerged as a cornerstone of innovation in the medical device sector, offering unparalleled sensitivity and specificity in clinical imaging and diagnostic applications. By harnessing the unique optical signatures of fluorophores when excited by specific wavelengths of light, developers can visualize tissue structures, guide surgical interventions, and monitor therapeutic responses with remarkable accuracy. This foundational technique has transformed traditional diagnostic modalities, driving enhanced patient outcomes through minimally invasive procedures and real-time visualization capabilities.

Moreover, the convergence of advances in imaging systems, spectroscopy techniques, and specialized fluorescent agents has ushered in a new era of medical device design. Recent developments in high-resolution imaging platforms, coupled with the integration of endogenous and exogenous fluorophores, have expanded the utility of fluorescence across a range of clinical settings. As a result, practitioners are now equipped to identify pathological changes at the cellular level, enabling earlier detection of disease and more precise intervention strategies. Simultaneously, regulatory frameworks have adapted to accommodate these innovations, balancing rigorous safety assessments with accelerated pathways for breakthrough technologies.

As the landscape evolves, this executive summary offers a structured overview of the critical factors shaping the medical device fluorescence market. It synthesizes transformative shifts, examines potential headwinds from tariff adjustments, and derives strategic insights from segmented market perspectives. The analysis also delves into regional dynamics, highlights key corporate strategies, and articulates actionable recommendations. Stakeholders will gain clarity on segmentation nuances, regional growth trajectories, and pathways to competitive differentiation, empowering data-driven decision-making in an increasingly complex landscape.

Tracking the Transformative Shifts Driven by Technological Breakthroughs, Regulatory Evolution, and Clinical Adoption Trends in Medical Fluorescence Applications

In recent years, medical device fluorescence has been propelled by a series of technological breakthroughs that are redefining diagnostic and therapeutic possibilities. Innovations in fluorescence imaging systems have delivered higher spatial resolution and deeper tissue penetration, while advances in spectroscopic methodologies have enhanced quantitative analysis of biomolecular interactions. At the same time, the development of novel fluorescent dyes and agents with improved photostability and targeted delivery mechanisms has widened the applicability of fluorescence across diverse clinical scenarios. These technical leaps are complemented by integration of artificial intelligence and machine learning algorithms, which optimize signal interpretation and reduce operator dependency, thereby improving workflow efficiency and diagnostic precision.

Regulatory frameworks have also undergone significant transformation to accommodate the pace of innovation. Updated guidelines and accelerated approval pathways have enabled faster clinical adoption of fluorescence-enabled devices, while ensuring patient safety through rigorous validation requirements. Moreover, evolving reimbursement policies are beginning to recognize the value proposition of fluorescence-guided interventions, incentivizing adoption in both large hospital systems and specialized diagnostic laboratories. Consequently, clinicians are increasingly integrating fluorescence modalities into routine practice, leveraging real-time visualization during surgery or minimally invasive procedures to minimize complications and enhance patient outcomes.

In parallel, advancements in material sciences are driving next-generation fluorophores that offer enhanced biocompatibility and multiplexing capabilities, while the proliferation of portable, point-of-care imaging devices is extending fluorescence benefits to resource-limited settings worldwide. This confluence of technological, regulatory, and clinical dynamics is charting a transformative trajectory for fluorescence in medical devices, compelling industry participants to innovate and collaborate in order to capitalize on emerging applications.

Analyzing the Cumulative Impact of United States Tariff Adjustments Scheduled for 2025 on Medical Device Fluorescence Supply Chains and Pricing Dynamics

The United States government's introduction of revised tariff schedules for 2025 marks a critical juncture for the medical device fluorescence industry. These adjustments encompass a range of imported components, from optical filters and light sources to specialized fluorophores and imaging modules. As a result, manufacturers face escalating import duties that could elevate the cost of raw materials and finished devices. The cumulative effect of these tariff changes is expected to manifest through altered supply chain structures, with potential shifts in supplier portfolios and increased emphasis on domestic production to mitigate cost exposure. Furthermore, the tariff revisions have prompted stakeholders to reassess long-term procurement strategies and evaluate the feasibility of integrating vertically aligned manufacturing processes.

From a cost perspective, the imposed duties are likely to pressure research and development budgets, potentially delaying innovation cycles and impacting pricing strategies across the sector. In response, many organizations are exploring alternative sourcing routes, negotiating supplier contracts to spread tariff impact, and investing in localized manufacturing facilities. Such strategic adjustments may entail increased collaboration with regional partners and adoption of modular design principles to reduce reliance on imported assemblies. Meanwhile, the prospect of higher device prices could alter customer purchasing behavior, prompting healthcare providers to prioritize cost-effective fluorescence solutions or alternative diagnostic modalities.

Ultimately, the cumulative impact of the 2025 tariffs underscores the need for proactive risk management and adaptive business models. By enhancing supply chain transparency, diversifying supplier networks, and aligning investment decisions with tariff scenarios, industry participants can navigate emerging trade barriers while sustaining innovation momentum.

Deriving Key Insights from Sectoral Segmentation Spanning Technology, Fluorophore Type, Application Modalities, and End-User Verticals for Fluorescence Market

Segmenting the fluorescence market by technology reveals distinct growth drivers and adoption profiles across imaging systems, spectroscopy platforms, and fluorescent dyes and agents. Fluorescence imaging systems have gained prominence due to their ability to deliver real-time visual feedback in surgical suites, while advances in spectroscopy techniques support detailed molecular analysis in laboratory settings. Meanwhile, fluorescent dyes and agents continue to evolve, offering improved photostability and target specificity that enhance both diagnostic accuracy and therapeutic monitoring. This technology-based perspective enables stakeholders to identify where innovation is most concentrated and where technical barriers may still require attention.

Considering the type of fluorophore employed, a clear dichotomy emerges between endogenous fluorophores and exogenous fluorophores. Endogenous compounds, which leverage naturally occurring biomolecules for signal generation, offer the advantage of reduced risk of adverse reactions, making them well suited for repeated imaging procedures. Exogenous fluorophores, in contrast, provide greater flexibility through chemical design, enabling targeted delivery and multifunctional labeling. This distinction influences device development pathways and regulatory considerations, as product safety, imaging depth, and multiplexing capabilities must be balanced against manufacturing and validation requirements.

When application comes into focus, the market spans fluorescence in catheters, fluorescence-guided surgery across cardiovascular surgery, neurosurgery, oncology surgery, and orthopedic surgery, imaging and diagnostics through endoscopic fluorescence imaging, fluorescence microscopy, fluorescence-based ophthalmic imaging, and in vivo fluorescence imaging, and therapeutic uses such as photodynamic therapy. Meanwhile, end-user segmentation underscores the varied purchasing and usage patterns of diagnostic laboratories, hospitals and clinics, and research and academic institutes. By integrating these four segmentation lenses, stakeholders can gain a holistic understanding of market priorities, uncover unmet needs, and tailor strategies that address the nuances of each segment, ensuring informed decisions across product development and commercial deployment.

Uncovering Regional Dynamics and Growth Patterns Across the Americas, Europe Middle East Africa, and Asia-Pacific to Drive Strategic Market Expansion

Regional dynamics in the Americas continue to be shaped by robust investment in healthcare infrastructure and significant innovation clusters in North America. The United States remains at the forefront of fluorescence-enabled medical device development, supported by strong venture funding, university research, and favorable reimbursement models. Canada follows with increasing adoption driven by national health priorities and collaborative research initiatives. In Latin American markets, economic variability and regulatory divergence present both challenges and opportunities, as local manufacturers gradually embrace fluorescence technologies to meet the rising demand for advanced diagnostic and surgical solutions in major urban centers.

Shifting attention to Europe, the Middle East, and Africa, the diversity of regulatory frameworks and healthcare funding models necessitates adaptive market entry strategies. Western European countries benefit from coordinated regulatory alignment and established clinical pathways for fluorescence-guided interventions, while emerging markets in Eastern Europe and the Middle East exhibit growing interest fueled by government-led healthcare modernization programs. In Africa, infrastructure constraints slow widespread adoption but also create potential for strategic partnerships aimed at pilot implementations in urban centers with academic medical facilities.

Asia-Pacific stands out as a rapidly expanding region, driven by rising healthcare expenditure, growing middle-class populations, and national initiatives to boost local device manufacturing. Key markets such as China, Japan, South Korea, and India are investing heavily in research and development, with an emphasis on indigenously produced fluorophores and imaging systems. At the same time, cost sensitivity in certain markets encourages adoption of portable point-of-care devices and simplified fluorescence-guided tools. Recognizing these regional distinctions empowers organizations to align product portfolios, navigate complex regulatory landscapes, and tailor commercial approaches that resonate with local dynamics.

Highlighting Competitive Strategies and Innovation of Leading Players in Medical Device Fluorescence to Reveal Differentiation and Collaboration Opportunities

Leading companies in the fluorescence medical device arena have demonstrated varied strategic approaches to maintain competitive advantage and foster innovation. Major device manufacturers have prioritized expansion of their fluorescence imaging portfolios through both in-house development and acquisition of specialized technology firms. By integrating next-generation detectors and AI-driven software into existing platforms, these organizations have enhanced diagnostic accuracy and streamlined clinical workflows. Simultaneously, chemical suppliers have invested in developing advanced fluorescent dyes with superior biocompatibility and multiplexing capabilities, forging partnerships with device makers to co-develop bundled solutions that meet stringent regulatory requirements.

Several key players have pursued geographical diversification, establishing regional research and production facilities to mitigate trade and tariff challenges while improving responsiveness to local market needs. Strategic alliances between imaging system producers and academic research centers have led to cutting-edge proof-of-concept studies, accelerating translation of novel fluorophores into clinical applications. Moreover, a number of companies have leveraged collaborative frameworks to coalesce around standardization efforts, aiming to harmonize data formats and performance metrics across different fluorescence modalities.

In addition, the competitive landscape is witnessing increased investment in personalized medicine applications, with firms exploring fluorescence-based tools for intraoperative guidance in oncology and neurosurgery. By targeting specific clinical domains, these organizations aim to differentiate their offerings through tailored protocols, comprehensive training programs, and post-market surveillance initiatives. Collectively, these strategic maneuvers underscore the dynamic nature of the market and highlight the importance of continuous innovation, cross-sector collaboration, and customer-centric solution development in sustaining long-term growth and market leadership.

Strategic Recommendations for Industry Leaders to Accelerate Innovation, Navigate Regulations, and Strengthen Market Position in Fluorescence Technologies

To capitalize on the evolving fluorescence landscape, industry leaders should adopt a multifaceted strategy that balances innovation with operational resilience. First, strengthening supply chain robustness through diversification of component sourcing and exploration of regional manufacturing hubs can mitigate risks associated with tariff volatility and logistical disruptions. At the same time, targeted investment in research and development of next-generation fluorophores and modular imaging platforms will position organizations at the vanguard of clinical innovation, enhancing their ability to address complex diagnostic and therapeutic challenges.

Second, fostering strategic collaborations is critical. Engaging with academic institutions, clinical research networks, and regulatory bodies early in the product development cycle can streamline validation processes and accelerate market access. Co-development partnerships with end-users enable iterative product refinement based on real-world feedback, driving adoption and creating compelling value propositions. Simultaneously, proactive regulatory engagement-such as participating in guidance consultations and standard-setting committees-will help shape favorable approval pathways and ensure compliance with emerging guidelines.

Third, companies should prioritize digital transformation by integrating artificial intelligence, cloud-based analytics, and telemedicine capabilities into their fluorescence solutions. These enhancements can boost workflow efficiency, support remote diagnostics, and unlock new applications in personalized medicine. Finally, delivering comprehensive training and support programs for healthcare providers will facilitate seamless clinical integration, minimize user resistance, and maximize patient benefits. By implementing these actionable recommendations, industry participants can navigate current headwinds and lay the groundwork for sustainable growth and differentiation in the fluorescence medical device sector.

Research Methodology Highlighting Primary and Secondary Data Collection, Validation Processes, and Analytical Frameworks Informing Fluorescence Market Insights

The research methodology underpinning this report combines rigorous primary and secondary data collection to ensure comprehensive coverage and depth of insight. Primary research involved structured interviews with key opinion leaders, including biomedical engineers, clinical practitioners, regulatory specialists, and procurement managers. In parallel, tailored surveys were administered to device manufacturers, chemical suppliers, and end-users to capture firsthand perspectives on performance criteria, adoption drivers, and market challenges. This qualitative input provided invaluable context and validated emerging themes in fluorescence technology development and commercialization.

Secondary research encompassed an extensive review of publicly available sources, such as peer-reviewed journal articles, patent filings, regulatory guidelines, conference proceedings, and corporate disclosures. Detailed analysis of product approvals and clinical trial registries supplemented the understanding of regulatory landscapes across major geographies. Additionally, market intelligence databases were consulted to map competitive positioning, historical innovation trajectories, and partnership activities, ensuring a well-rounded view of industry dynamics.

To uphold data integrity, all quantitative and qualitative data points underwent triangulation through cross-referencing among multiple sources. Validation processes included consistency checks, logic screening, and reconciliation with expert feedback to eliminate discrepancies. Analytical frameworks-such as SWOT analysis, PESTLE evaluation, and value chain mapping-were applied to structure insights and facilitate strategic interpretation. This robust methodological approach guarantees that the findings and recommendations presented are grounded in reliable evidence and reflective of real-world market conditions.

Synthesizing Critical Findings and Projecting Strategic Implications to Guide Stakeholders Towards Future Innovations and Sustainable Growth in Fluorescence

This executive summary has distilled the most impactful developments in medical device fluorescence, highlighting technological breakthroughs in imaging systems, spectroscopy, and fluorophore design. It has examined forthcoming tariff adjustments and their potential to reshape supply chains and cost structures. By analyzing segmentation across technology, fluorophore type, application domains, and end-user groups, it has offered a nuanced perspective on market priorities. Regional insights detailed the differing dynamics of the Americas, Europe Middle East and Africa, and Asia-Pacific, while corporate analysis showcased how leading players are leveraging partnerships, localized manufacturing, and product innovation to maintain competitive advantage. The actionable recommendations provide a clear roadmap for navigating regulatory complexities, strengthening resilience, and driving continuous innovation.

As stakeholders contemplate the next phase of growth, the strategic implications of these findings underscore the importance of agility, collaboration, and patient-centric development. Organizations that proactively adjust sourcing strategies, engage with regulatory authorities, and invest in digital integration will be better positioned to capture emerging opportunities. Ultimately, the integration of fluorescence technologies into mainstream clinical practice promises enhanced diagnostic accuracy, more targeted therapeutic interventions, and improved patient outcomes. By synthesizing these insights, decision-makers can align their efforts to drive sustainable value creation in the rapidly evolving fluorescence-enabled medical device market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Expansion of near-infrared fluorescence probes for deeper tissue imaging in oncology applications
  • 5.2. Integration of near-infrared fluorescence imaging with robotic surgery systems to enhance tumor visualization
  • 5.3. Adoption of AI-powered fluorescence analysis software for enhanced tissue differentiation
  • 5.4. Emergence of wearable fluorescence biosensors for continuous monitoring of metabolic biomarkers
  • 5.5. Collaborations between hospitals and biotech firms to commercialize novel fluorescent contrast agents
  • 5.6. Advances in real-time intraoperative fluorescence-guided tumor margin detection tools for oncology
  • 5.7. Development of dual-modality clinical imaging platforms combining fluorescence and ultrasound modalities
  • 5.8. Growth of handheld fluorescence imaging devices for vascular mapping and dermatological assessments
  • 5.9. Regulatory harmonization and standardization efforts driving global commercialization of fluorescence medical devices
  • 5.10. Rising demand for three-dimensional fluorescence microscopy in minimally invasive diagnostic procedures

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Fluorescence in Medical Device Market, by Technology

  • 8.1. Introduction
  • 8.2. Fluorescence Imaging Systems
  • 8.3. Fluorescence Spectroscopy
  • 8.4. Fluorescent Dyes & Agents

9. Fluorescence in Medical Device Market, by Fluorophore Type

  • 9.1. Introduction
  • 9.2. Endogenous Fluorophores
  • 9.3. Exogenous Fluorophores

10. Fluorescence in Medical Device Market, by Application

  • 10.1. Introduction
  • 10.2. Fluorescence in Catheters
  • 10.3. Fluorescence-Guided Surgery
    • 10.3.1. Cardiovascular Surgery
    • 10.3.2. Neurosurgery
    • 10.3.3. Oncology Surgery
    • 10.3.4. Orthopedic Surgery
  • 10.4. Imaging & Diagnostics
    • 10.4.1. Endoscopic Fluorescence Imaging
    • 10.4.2. Fluorescence Microscopy
    • 10.4.3. Fluorescence-Based Ophthalmic Imaging
    • 10.4.4. In Vivo Fluorescence Imaging
  • 10.5. Therapeutic

11. Fluorescence in Medical Device Market, by End-User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals & Clinics
  • 11.4. Research & Academic Institutes

12. Americas Fluorescence in Medical Device Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Fluorescence in Medical Device Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Fluorescence in Medical Device Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. ADVACAM s.r.o.
    • 15.3.2. Arthrex, Inc.
    • 15.3.3. Bruker Corporation
    • 15.3.4. Carl Zeiss AG.
    • 15.3.5. Getinge AB
    • 15.3.6. Hamamatsu Photonics K.K.
    • 15.3.7. KARL STORZ SE & Co. KG
    • 15.3.8. Leica Microsystems GmbH
    • 15.3.9. LI-COR Biotech, LLC
    • 15.3.10. Mauna Kea Technologies
    • 15.3.11. Medtronic International Trading Sarl
    • 15.3.12. MolecuLight Inc.
    • 15.3.13. Olympus Corporation of the Americas
    • 15.3.14. OnLume Inc.
    • 15.3.15. Optomedic.
    • 15.3.16. PerkinElmer U.S. LLC
    • 15.3.17. PicoQuant GmbH
    • 15.3.18. Shimadzu Corporation
    • 15.3.19. Stryker Corporation
    • 15.3.20. Xuzhou Hengjia Electronic Technology Co., Ltd.
    • 15.3.21. SurgiMab SAS

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. FLUORESCENCE IN MEDICAL DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. FLUORESCENCE IN MEDICAL DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. FLUORESCENCE IN MEDICAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. FLUORESCENCE IN MEDICAL DEVICE MARKET: RESEARCHAI
  • FIGURE 24. FLUORESCENCE IN MEDICAL DEVICE MARKET: RESEARCHSTATISTICS
  • FIGURE 25. FLUORESCENCE IN MEDICAL DEVICE MARKET: RESEARCHCONTACTS
  • FIGURE 26. FLUORESCENCE IN MEDICAL DEVICE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. FLUORESCENCE IN MEDICAL DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENT DYES & AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENT DYES & AGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOGENOUS FLUOROPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOGENOUS FLUOROPHORES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY EXOGENOUS FLUOROPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY EXOGENOUS FLUOROPHORES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IN CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IN CATHETERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ONCOLOGY SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ONCOLOGY SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOSCOPIC FLUORESCENCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOSCOPIC FLUORESCENCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-BASED OPHTHALMIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-BASED OPHTHALMIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IN VIVO FLUORESCENCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IN VIVO FLUORESCENCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 62. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 75. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 76. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 77. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 89. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 90. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 101. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 102. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 103. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 113. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 115. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 121. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 122. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 123. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 124. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 125. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 127. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 131. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 132. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 133. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 134. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 135. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 136. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 163. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 165. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 169. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 170. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 171. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 172. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 173. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 174. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 175. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 177. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 182. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 183. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 184. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 185. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 186. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 187. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 189. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 193. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 194. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 195. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 196. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 197. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 198. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 199. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 201. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 205. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 206. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 207. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 208. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 209. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 210. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 211. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 213. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 217. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 218. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 219. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 220. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 221. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 222. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 242. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 244. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 246. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 254. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 256. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 258. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 259. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 265. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 266. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 267. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 268. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 269. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 270. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 278. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 280. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 281. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 282. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 283. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 285. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 289. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 290. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 291. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 292. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 293. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 294. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 295. FINLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLIO